Is a complete BNTC research report available?

No complete published report is available for Benitec Biopharma Inc. (BNTC) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Benitec Biopharma Inc. (BNTC)

NASDAQ: BNTC · USD

$11.4

+0.00 (0.0%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-24 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first BNTC analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	393M
Net income (ttm)	-41.5M
EPS (ttm)	-$0.93
Shares out	34.4M
Volume	128,072
Beta	0.25
Price target	$25.8	+125.5%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -41.5M
EPS (ttm): -$0.93
Market cap: 393M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All BNTC indicators

Market & fundamental data

Available fields

188

Groups with data

Currency

USD

Showing 188 of 188 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001552795
Company name	Benitec Biopharma Inc.
Country	United States
Country code	US
Cusip	08205P209
Employees	19
Employees Change	3%
Employees Change Percent	18.75
Enterprise value	$207.1M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US08205P2092
Last refreshed	2026-07-24
Market cap	$393M
Market cap category	Small-Cap
Price	$11.44
Price currency	USD
Sector	Healthcare
Sector PE	44.59
Sector PE Fwd	23.48
Sic	2834
Symbol	BNTC
Website	https://benitec.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-10.63%
EV Sales Forward	22.75x
FCF yield	-5.07%
P/B ratio	2.14x
PS Forward	42.96x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-41.5M
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Profit Per Employee	$-2.2M
ROA	-19.93
Roa5y	-89.13
ROCE	-29.36
ROE	-29.58
Roe5y	-332.7
ROIC	-20.6

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-31.06%
Cagr1y	1.6%
Cagr3y	45.59%
Cagr5y	-29.56%
EPS Growth Quarters	1
EPS Growth Years	5
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$187M
Cash	$184.8M
Current Assets	$186M
Current Liabilities	$3.3M
Debt	$876,000
Debt Equity	$0
Equity	$183.3M
Liabilities	$3.7M
Long Term Assets	$983,000
Long Term Liabilities	$394,000
Net Cash	$183.9M
Net Cash By Market Cap	$47.04
Net Cash Growth	79.18%
Net Debt Equity	$-1
Tangible Book Value	$183.3M
Tangible Book Value Per Share	$5.34
WACC	5.62

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	56.82
Net Working Capital	$-1.5M
Quick ratio	56.43
Working Capital	$182.7M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-37.41%
Dividend per share	$0
Dividend Yield	0%
Last Dividend	$0.7

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-97.57%
1Y total return	1.6%
200-day SMA	12.45
3Y total return	208.69%
50-day SMA	11.93
50-day SMA vs 200-day SMA	50under200
5Y total return	-82.66%
All Time High	5,916
All Time High Change	-99.81%
All Time High Date	2014-07-07
All Time Low	1.86
All Time Low Change	515.05%
All Time Low Date	2023-08-09
ATR	0.79
Beta	0.25
Beta1y	2.05
Beta2y	0.84
Ch YTD	-15.07
High	11.96
High52	16.76
High52 Date	2025-10-27
High52ch	-31.74%
Low	11.1
Low52	9.85
Low52 Date	2026-02-17
Low52ch	16.14%
Ma50ch	-4.07%
Price vs 200-day SMA	-8.08%
RSI	37.65
RSI Monthly	44.84
RSI Weekly	47.31
Sharpe ratio	0.25x
Sortino ratio	0.44
Total Return	-37.41%
Tr YTD	-15.07
Tr1m	-6.99%
Tr1w	-9.64%
Tr3m	-11.73%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	6
Analyst Count Top	4
Analyst Price Target Top	$28.5
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.27
Operating Income	$-46.6M
Price target	$25.8
Price Target Change	$126
Price Target Change Top	$149

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	17,925,018%
Float Percent	52.18%
Shares Insiders	2.65%
Shares Institutions	54.02%
Shares Out	34,354,334
Shares Qo Q	7.43%
Shares Yo Y	37.41%
Short Float	12.43%
Short Ratio	15.07
Short Shares	6.49

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-46.1M
Average Volume	140,510.45x
Bv Per Share	5.34
CAPEX	$-26,000
Ch10y	-97.57
Ch1m	-6.99
Ch1w	-9.64
Ch1y	1.6
Ch3m	-11.73
Ch3y	208.7
Ch5y	-82.66
Ch6m	-10.83
Change	0%
Change From Open	2.05
Close	11.44
Days Gap	-2.01
Depreciation Amortization	55,000
Dollar Volume	1,465,143.7
Earnings Date	2026-05-14
Earnings Time	bmo
EBIT	$-53.9M
EBITDA	$-53.5M
EPS	$-0.93
F Score	2
FCF	$-19.8M
FCF EV Yield	-9.57x
FCF Per Share	$-0.58
Financing CF	101,480,000
Fiscal Year End	June
Founded	1,995
Investing CF	-26,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-14
Last Report Date	2026-03-31
Last Split Date	2023-07-26
Last Split Type	Reverse
Last10k Filing Date	2019-10-30
Ma150	11.9
Ma150ch	-3.83%
Ma20	12.78
Ma20ch	-10.46%
Net CF	81,429,000
Next Earnings Date	2026-09-21
Open	11.21
Optionable	Yes
Position In Range	39.53
Post Close	11.44
Postmarket Change Percent	-0.17
Postmarket Price	$11.42
Ppne	916,000
Price Date	2026-07-23
Ptbv Ratio	2.13
Relative Volume	0.91x
Share Based Comp	26,260,000
Tr6m	-10.83%
Us State	California
Volume	128,072

Benitec Biopharma Inc. (BNTC)

Coverage state: Market snapshot only — no published research

Generate the first BNTC analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · BNTC

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BNTC indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on BNTC

Frequently asked questions